Related Experiment Video
Updated: Aug 26, 2026

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
Atypical antipsychotics: pharmacokinetics, therapeutic drug monitoring and pharmacological interactions
Maria Augusta Raggi1, Roberto Mandrioli, Cesare Sabbioni
1Alma Mater Studiorum - University of Bologna, Faculty of Pharmacy, Department of Pharmaceutical Sciences, Via Belmeloro 6, 40126 Bologna, Italy. raggima@alma.unibo.it
Abstract:
The development of new "atypical" antipsychotic agents, which are safer than classical neuroleptics and also active against the negative symptoms and neurocognitive deficits caused by the illness, has produced a significant advancement in the treatment of schizophrenia. The atypical (or "second generation") antipsychotics have several therapeutical properties in common, however they can significantly differ with regard to clinical potency and side effects. The main features regarding pharmacodynamics, pharmacokinetics and pharmacological interactions of the most important atypical antipsychotics, namely clozapine, olanzapine, quetiapine and risperidone, are treated herein. Several analytical methods available for the therapeutic drug monitoring of these drugs are also presented, as well as the novel formulations, which can notably improve the therapy of schizophrenia. Other very recent atypical agents, such as ziprasidone, aripiprazole, iloperidone, sertindole and zotepine will also be briefly described.
Related Concept Videos
Pharmacokinetics: Drug–Drug Interactions
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring: Drug Analysis Methods
Drug Therapy
Antianxiety Medications
Antipsychotic Drugs: Typical and Atypical Agents